AstraZeneca | AZN - Sales Revenues


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

AstraZeneca

AstraZeneca reported $10.88B in Sales Revenues for its fiscal quarter ending in March of 2023.


Sales Change
AbbVie ABBV:US USD 12.23B 2.9B
Alcon AG ALC:SW USD 2.35B 181M
Almirall SA ALM:SM EUR 426.61M 10.02M
Amgen AMGN:US USD 6.1B 734M
argenx SE ARGX:BB USD 219.14M 37.02M
Artemis Alpha ATS:LN GBP -15830000 10.03M
AstraZeneca AZN:LN USD 10.88B 328M
Bayer BAYN:GR EUR 14.39B 2.39B
Biogen BIIB:US USD 2.46B 81M
Bristol-Myers Squibb BMY:US USD 11.34B 69M
Eli Lilly LLY:US USD 6.96B 341.8M
Fresenius FRE:GR EUR 10.23B 418M
Fresenius Medical Care FME:GR EUR 4.7B 292.8M
Galapagos GLPG:NA EUR 187.17M 74.67M
Genmab GEN:DC DKK 2.85B 2.37B
Gilead Sciences GILD:US USD 6.35B 1.04B
GlaxoSmithKline GSK:LN GBP 6.95B 425M
Grifols GRF:SM EUR 1.56B 18.59M
Hikma Pharmaceutical HIK:LN USD 1.3B 91M
Lonza Group LONN:SW CHF 3.24B 259M
Merck MRK:GR EUR 5.29B 367M
Merck & Co MRK:US USD 14.49B 657M
Novartis NOVN:VX USD 13.21B 207M
Orion ORNBV:FH EUR 277.9M 16.6M
Pfizer PFE:US USD 18.28B 6.01B
Philips PHIA:NA EUR 4.17B 1.26B
Recordati REC:IM EUR 551.36M 75.6M
Regeneron Pharmaceuticals REGN:US USD 3.16B 252.3M
Roche Holding ROG:VX CHF 30.99B 1.31B
Sanofi SAN:FP EUR 10.22B 503M
UCB UCB:BB EUR 2.59B 333M